Osimertinib — Dosing in CKD & Dialysis

Osimertinib (Tyrosine Kinase Inhibitor): renal dosing adjustments, dialyzability (Not measurably removed in one hemodialysis patient: osimertinib concentrations measured before, after and without hemodialysis showed that hemodialysis did not affect its pharmacokinetics (Matsunashi 2020, PMID 3148698

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.